• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

byRebecca SeligaandAlex Gipsman, MD
December 24, 2021
in Chronic Disease, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. This cohort study analyzed health care claims from 2008-2019 and found that benzodiazepine prescribing in adolescents and young adults peaked in 2015 and 2013 respectively, and has been declining since.

2. Only approximately one quarter of cases involved an approved indication for benzodiazepine use, raising alarms that these medications are frequently being prescribed for indications that are not evidence-based.

Evidence Rating Level: 2 (Good)

Study Rundown (retrospective cohort): In addition to being dangerous and addictive substances themselves, benzodiazepines are also associated with an increased risk of opioid-related mortality in children and adolescents. This study sought to analyze and describe trends in youth benzodiazepine prescribing between 2008 and 2019. Researchers collected health care claim data from a commercial insurance plan that covered over four million adolescents (aged 13-18), and six million young adults (aged 19-25). Overall, benzodiazepines were prescribed at least once to 1.8% of adolescents and 4.0% of young adults, with diazepam being most the most common choice in adolescents and alprazolam in young adults. A simultaneous opioid prescription was provided to 26.1% of the adolescents receiving benzodiazepines, and 24.0% of young adults. Prevalence of benzodiazepine dispensing peaked in 2015 for adolescents and in 2013 for young adults, and subsequently decreased steadily until the end of the study period. Alarmingly, only one quarter of cases involved an approved indication for benzodiazepine use.

This study highlights the frequency of use of these dangerous medications despite a lack of evidence-based indications. Clinicians should remain judicious in their use of these medications, only prescribing when necessary for approved indications and limiting co-prescription with opioids when possible. This study is strengthened by its very large cohort, though limited in that data was gathered from a single private insurance provider and may not be generalizable to those who use Medicaid or are uninsured. It also relies on diagnostic coding to assess indications for prescription, which can be unreliable.

Click to read the study in JAMA Pediatrics

Relevant Reading: Child and adolescent benzodiazepine exposure and overdose in the United States: 16 years of poison center data

RELATED REPORTS

Physical activity may be helpful in treating depressive symptoms in children and adolescents

Weekly semaglutide associated with reduced BMI in adolescents with obesity

Ceftriaxone use is not associated with increased free bilirubin in term neonates with sepsis

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adolescent medicinebenzodiazepineopioidspharmacology
Previous Post

Co-occurring substance use disorders are common in pregnant women

Next Post

No Difference in Antibody or Humoral Responses Among Kidney Transplant Recipients Vaccinated with a 3rd Dose of mRNA or Adenovirus Vector Vaccine

RelatedReports

Certain financial incentive programs may promote increased physical activity
Chronic Disease

Physical activity may be helpful in treating depressive symptoms in children and adolescents

January 18, 2023
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Chronic Disease

Weekly semaglutide associated with reduced BMI in adolescents with obesity

December 26, 2022
Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia
Infectious Disease

Ceftriaxone use is not associated with increased free bilirubin in term neonates with sepsis

November 22, 2022
#VisualAbstract: Psilocybin can reduce depressive symptoms in patients with treatment-resistant depression
StudyGraphics

#VisualAbstract: Psilocybin can reduce depressive symptoms in patients with treatment-resistant depression

November 18, 2022
Next Post
Compliance-linked incentives increase infant immunizations rates in rural India

No Difference in Antibody or Humoral Responses Among Kidney Transplant Recipients Vaccinated with a 3rd Dose of mRNA or Adenovirus Vector Vaccine

Type 2 diabetes associated with reduction in disability-free life years

2 Minute Medicine Rewind December 27, 2021

Children’s hospital visits for suicide ideation and attempts are increasing

Addition of lithium not associated with reduction in suicide incidence in veterans with a recent suicide event

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options